Drug recall · February 14, 2018
Aripiprazole Tablets recall
Why: CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specifications.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx Only, Manufactured for Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, By; Hetero Hetero Labs Limited Unit V Polepallly Jadcheria Mahaboob Nagar - 509 301 India, NDC 31722-827-30
- Lots / codes
Lot #: ARI17089, ARI17090, Exp. 5/2019
- Quantity
- 3000 bottles
- Company
- Hetero Labs, Ltd. - Unit III, Hyderabad, N/A
- Distribution
- NJ Only
- Initiated
- January 10, 2018 · Voluntary: Firm initiated
- Classified
- March 13, 2018
- Reported
- February 14, 2018
- Ended
- September 21, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Aripiprazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.